IMMUNOGENIC NANOMEDICINE COMPOSITION AND PREPARATION AND USES THEREOF

The invention belongs to the field of immunotherapy and vaccines. More particularly, the invention relates to a pharmaceutical composition comprising nanoparticles being composed of macromolecules and linear polyethyleneimine (1-PEI) or 1-PEI derivative in a pharmaceutically acceptable liquid formul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PINTER, ISTVAN, GRUBER, LAJOS, PANDUR, JOZSEF, MOLNAR, MIKLOS, OETVOES, LASZLO, GARACZI, EDINA, CSOERGO, SANDORNE BATA ZSUZSANNA, LISZIEWICZ, JULIANNA, HAMAR, PETER, KEMENY, LAJOS, LORINCZ, ORSOLYA, SOMOGYI, ESZTER, KOEKENY, GABOR, SZABO, KORNELIA AGNES, TOKE, ENIKO, MOZES, MIKLOS, SZOLLAR, LAJOS
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention belongs to the field of immunotherapy and vaccines. More particularly, the invention relates to a pharmaceutical composition comprising nanoparticles being composed of macromolecules and linear polyethyleneimine (1-PEI) or 1-PEI derivative in a pharmaceutically acceptable liquid formulation, as well as a method for the preparation thereof. Uses of said compositions are also provided. L'invention appartient au domaine de l'immunothérapie et des vaccins. Plus particulièrement, l'invention porte sur une composition pharmaceutique comprenant des nanoparticules composées de macromolécules et de polyéthylèneimine linéaire (1-PEI) ou d'un dérivé de 1-PEI dans une formulation liquide pharmaceutiquement acceptable, ainsi que sur un procédé pour la préparation de celle-ci. L'invention porte également sur des utilisations desdites compositions.